Although the field of pharmacogenetics has existed for decades, practioners have been slow
to implement pharmacogenetic testing in clinical care. Numerous publications describe the …

Clinical implementation of pharmacogenomics (PGx) leads to personalized medicine, which
improves the efficacy, safety, and cost-effectiveness of treatments. Although PGx-based …

Background The use of pharmacogenomic testing in the clinical setting has the potential to
improve the safety and effectiveness of drug therapy, yet studies have revealed that …

Purpose: Although targeted sequencing improves outcomes for many cancer patients, it
remains uncertain how somatic and germ-line whole-exome sequencing (WES) will …

Purpose The development and implementation of a multidisciplinary pharmacogenomics
clinic within the framework of an established community-based medical genetics program …

Nephrotic syndrome is one of the most common glomerular disorders in childhood.
Glucocorticoids have been the cornerstone of the treatment of childhood nephrotic …

Introduction Racial and ethnic categories are frequently used in pharmacogenetics literature
to stratify patients; however, these categories can be inconsistent across different studies. To …

Importance Pharmacogenomic (PGx) testing provides preemptive pharmacotherapeutic
guidance regarding the lack of therapeutic benefit or adverse drug reactions of PGx targeted …

Genomics is becoming an increasingly important part of health care, and pharmacists are
well-positioned to be practice-based leaders in pharmacogenomics and precision medicine …

Since the human genome project in 2003, the view of personalized medicine to improve
diagnosis and cure diseases at the molecular level became more real. Sequencing the …